UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009978 |
|---|---|
| Receipt number | R000011691 |
| Scientific Title | Pilot Study: Paclitaxel plus Bevacizumab followed by FEC100 in HER2-negative locally (stage IIIB/IIIC) advanced breast cancer. |
| Date of disclosure of the study information | 2013/02/06 |
| Last modified on | 2017/02/09 09:06:18 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/02/06 14:31:40 | ||
| 2 | Update | 2015/02/06 09:32:03 | Recruitment status |
|
| 3 | Update | 2016/02/08 08:24:55 | TEL Address TEL |
|
| 4 | Update | 2016/02/08 08:27:04 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 5 | Update | 2017/02/09 09:06:18 | Recruitment status |
